Illumina (ILMN) Competitors $136.02 +2.02 (+1.51%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, community ranking, analyst recommendations, dividends, media sentiment, institutional ownership and profitability. Does the media favor A or ILMN? In the previous week, Agilent Technologies had 10 more articles in the media than Illumina. MarketBeat recorded 25 mentions for Agilent Technologies and 15 mentions for Illumina. Illumina's average media sentiment score of 0.86 beat Agilent Technologies' score of 0.35 indicating that Illumina is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 10 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Illumina 8 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Do analysts prefer A or ILMN? Agilent Technologies currently has a consensus target price of $143.62, suggesting a potential upside of 6.77%. Illumina has a consensus target price of $165.95, suggesting a potential upside of 22.00%. Given Illumina's stronger consensus rating and higher probable upside, analysts clearly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 1 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.43Illumina 0 Sell rating(s) 8 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 2.70 Does the MarketBeat Community favor A or ILMN? Illumina received 244 more outperform votes than Agilent Technologies when rated by MarketBeat users. However, 71.09% of users gave Agilent Technologies an outperform vote while only 65.70% of users gave Illumina an outperform vote. CompanyUnderperformOutperformAgilent TechnologiesOutperform Votes86371.09% Underperform Votes35128.91% IlluminaOutperform Votes110765.70% Underperform Votes57834.30% Which has preferable earnings & valuation, A or ILMN? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.51B5.94$1.29B$4.4230.43Illumina$4.39B4.91-$1.16B-$9.96-13.66 Which has more risk and volatility, A or ILMN? Agilent Technologies has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Do institutionals & insiders have more ownership in A or ILMN? 87.4% of Agilent Technologies shares are held by institutional investors. Comparatively, 89.4% of Illumina shares are held by institutional investors. 0.3% of Agilent Technologies shares are held by company insiders. Comparatively, 0.2% of Illumina shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is A or ILMN more profitable? Agilent Technologies has a net margin of 19.80% compared to Illumina's net margin of -36.10%. Agilent Technologies' return on equity of 25.43% beat Illumina's return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies19.80% 25.43% 13.79% Illumina -36.10%7.29%3.40% SummaryAgilent Technologies beats Illumina on 11 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.25B$5.42B$5.12B$9.07BDividend YieldN/A0.42%4.91%4.22%P/E Ratio-13.6625.1891.3417.19Price / Sales4.914.291,116.63116.80Price / Cash41.2044.4542.5837.86Price / Book3.762.204.794.78Net Income-$1.16B$2.05M$120.07M$225.60M7 Day Performance-5.46%-2.70%-1.90%-1.24%1 Month Performance-0.78%-2.89%11.43%3.06%1 Year Performance-3.00%-28.70%30.59%16.50% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.4809 of 5 stars$136.02+1.5%$165.95+22.0%-0.6%$21.25B$4.39B-13.669,300High Trading VolumeAAgilent Technologies4.7188 of 5 stars$137.77-0.9%$143.62+4.2%-2.7%$39.59B$6.51B31.4518,100Analyst ForecastAnalyst RevisionMTDMettler-Toledo International3.9519 of 5 stars$1,266.04-0.9%$1,351.25+6.7%+3.7%$26.72B$3.76B34.4317,300Positive NewsWATWaters3.7196 of 5 stars$376.17-0.6%$375.85-0.1%+13.9%$22.34B$2.91B36.097,900TECHBio-Techne4.6341 of 5 stars$76.47+1.0%$82.00+7.2%-3.5%$12.15B$1.17B81.073,100CRLCharles River Laboratories International4.5205 of 5 stars$191.06+0.3%$214.00+12.0%-19.8%$9.77B$4.06B23.8421,800BIOBio-Rad Laboratories4.3526 of 5 stars$339.83+1.1%$394.20+16.0%+6.2%$9.51B$2.58B-12.308,030Analyst RevisionPositive NewsBRKRBruker4.9904 of 5 stars$57.76+0.1%$74.70+29.3%-21.7%$8.76B$2.96B27.759,707Analyst ForecastPACBPacific Biosciences of California1.5546 of 5 stars$2.05+4.6%$2.95+44.1%-79.8%$561.41M$200.52M-1.46730HBIOHarvard Bioscience1.2863 of 5 stars$2.12-1.9%N/A-57.8%$92.47M$97.73M-6.55490TMOThermo Fisher Scientific4.7674 of 5 stars$531.99+1.0%$652.30+22.6%+0.9%$203.49B$42.86B33.03122,000 Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ILMN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ILMN Stock Alerts